TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Eql Pharma AB
Closing information (x1000 DKK)
| Closing information | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Turnover |
170,947
|
171,696
|
294,794 |
| Financial expenses |
3,709
|
1,567
|
2,068 |
| Earnings before taxes |
18,510
|
25,742
|
25,875 |
| EBITDA |
26,774
|
32,782
|
32,388 |
| Total assets |
241,865
|
188,728
|
171,147 |
| Current assets |
127,983
|
110,469
|
88,817 |
| Current liabilities |
104,865
|
76,612
|
71,050 |
| Equity capital |
115,009
|
102,228
|
88,942 |
| - share capital |
846
|
864
|
941 |
| Employees (average) |
21
|
18
|
13 |
Financial ratios
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Solvency |
47.6%
|
54.2%
|
52.0% |
| Turnover per employee |
8,140
|
9,539
|
22,676 |
| Profit as a percentage of turnover |
10.8%
|
15.0%
|
8.8% |
| Return on assets (ROA) |
9.2%
|
14.5%
|
16.3% |
| Current ratio |
122.0%
|
144.2%
|
125.0% |
| Return on equity (ROE) |
16.1%
|
25.2%
|
29.1% |
| Change turnover |
2,753
|
-98,983
|
165,912 |
| Change turnover % |
2%
|
-37%
|
129% |
| Chg. No. of employees |
3
|
5
|
3 |
| Chg. No. of employees % |
17%
|
38%
|
30% |
Total value of public sale
| Fiscal year | 2024/03 (consolidated) | 2023/03 (consolidated) | 2022/03 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.